Design, Synthesis, and Biological Evaluation of Novel Phenoxy Acetic Acid Derivatives As Selective COX-2 Inhibitors Coupled with Comprehensive Bio-Pharmacological Inquiry, Histopathological Profiling, and Toxicological Scrutiny

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2024 Mar 28

PMID 38542945

Authors

Najla A Alshaye

Mohamed K Elgohary

Mahmoud S Elkotamy

Hatem A Abdel-Aziz

Affiliations

Soon will be listed here.

Abstract

COX-2 plays a key role in converting arachidonic acid into prostaglandins. This makes it a significant target for treating inflammation. Selective COX-2 inhibitors have marked a new phase in inflammatory treatment, providing significant effectiveness while reducing negative side effects. Herein, we aimed at the design and synthesis of new anti-inflammatory agents -, -, -, and - with expected selective inhibition for COX-2. Compounds -, , and - showed significant COX-2 inhibition with IC in the range of 0.06-0.09 μM, indicating powerful pharmacological potential. In light of this, eight compounds were selected for further testing in vivo to assess their selectivity toward COX-1/COX-2 enzymes with the ability to reduce paw thickness. Compounds and showed significant anti-inflammatory effects without causing stomach ulcers, as they showed significant in vivo inhibition for paw thickness at 63.35% and 46.51%, as well as paw weight at 68.26% and 64.84%. Additionally, the tested compounds lowered TNF-α by 61.04% and 64.88%, as well as PGE-2 by 60.58% and 57.07%, respectively. Furthermore, these potent compounds were thoroughly analyzed for their pain-relieving effects, histological changes, and toxicological properties. Assessing renal and stomach function, as well as measuring liver enzymes AST and ALT, together with kidney indicators creatinine and urea, offered valuable information on their safety profiles. Molecular modeling studies explain the complex ways in which the strong interacts with the COX-2 enzyme. This comprehensive strategy emphasizes the therapeutic potential and safety profiling of these new analogues for managing inflammation.

References

Li L, Musa Chiroma S, Hashim T, Adam S, Mohd Moklas M, Yusuf Z . Antioxidant and anti-inflammatory properties of alkaloid leaf extract. Heliyon. 2020; 6(6):e04141. PMC: 7330067. DOI: 10.1016/j.heliyon.2020.e04141. View

Hamdy S, Menze E, El Hefnawy H, Azzam S, Aboutabl E . Anti-inflammatory Activity of L. aerial parts and Isolation of the Main Phytochemicals. Iran J Pharm Res. 2021; 19(3):34-44. PMC: 7758006. DOI: 10.22037/ijpr.2020.1101154. View

Cortes-Salva M, Shrestha S, Singh P, Morse C, Jenko K, Montero Santamaria J . 2-(4-Methylsulfonylphenyl)pyrimidines as Prospective Radioligands for Imaging Cyclooxygenase-2 with PET-Synthesis, Triage, and Radiolabeling. Molecules. 2018; 23(11). PMC: 6278313. DOI: 10.3390/molecules23112850. View

Abdel-Aziz H, Al-Rashood K, ElTahir K, Suddek G . Synthesis of N-benzenesulfonamide-1H-pyrazoles bearing arylsulfonyl moiety: novel celecoxib analogs as potent anti-inflammatory agents. Eur J Med Chem. 2014; 80:416-22. DOI: 10.1016/j.ejmech.2014.04.065. View

Chowdhury M, Abdellatif K, Dong Y, Das D, Yu G, Velazquez C . Synthesis and biological evaluation of salicylic acid and N-acetyl-2-carboxybenzenesulfonamide regioisomers possessing a N-difluoromethyl-1,2-dihydropyrid-2-one pharmacophore: dual inhibitors of cyclooxygenases and 5-lipoxygenase with.... Bioorg Med Chem Lett. 2009; 19(24):6855-61. DOI: 10.1016/j.bmcl.2009.10.083. View

Pang L, Liu C, Gong G, Quan Z . Synthesis, and biological evaluation of novel lappaconitine derivatives as potential anti-inflammatory agents. Acta Pharm Sin B. 2020; 10(4):628-645. PMC: 7161710. DOI: 10.1016/j.apsb.2019.09.002. View

Bertolini A, Ottani A, Sandrini M . Dual acting anti-inflammatory drugs: a reappraisal. Pharmacol Res. 2001; 44(6):437-50. DOI: 10.1006/phrs.2001.0872. View

Conaghan P . A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol Int. 2011; 32(6):1491-502. PMC: 3364420. DOI: 10.1007/s00296-011-2263-6. View

Mert T, Yaman S . Pro-inflammatory or anti-inflammatory effects of pulsed magnetic field treatments in rats with experimental acute inflammation. Environ Sci Pollut Res Int. 2020; 27(25):31543-31554. DOI: 10.1007/s11356-020-09401-z. View

10.

Bhandari S, Parikh J, Bothara K, Chitre T, Lokwani D, Devale T . Design, synthesis, and evaluation of anti-inflammatory, analgesic, ulcerogenicity, and nitric oxide releasing studies of novel indomethacin analogs as non-ulcerogenic derivatives. J Enzyme Inhib Med Chem. 2010; 25(4):520-30. DOI: 10.3109/14756360903357585. View

11.

Lamie P, Philoppes J, Azouz A, Safwat N . Novel tetrazole and cyanamide derivatives as inhibitors of cyclooxygenase-2 enzyme: design, synthesis, anti-inflammatory evaluation, ulcerogenic liability and docking study. J Enzyme Inhib Med Chem. 2017; 32(1):805-820. PMC: 6445242. DOI: 10.1080/14756366.2017.1326110. View

12.

Lees P, Giraudel J, Landoni M, Toutain P . PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology. J Vet Pharmacol Ther. 2004; 27(6):491-502. DOI: 10.1111/j.1365-2885.2004.00618.x. View

13.

Kruger N . The Bradford method for protein quantitation. Methods Mol Biol. 1994; 32:9-15. DOI: 10.1385/0-89603-268-X:9. View

14.

Sohail R, Mathew M, Patel K, Reddy S, Haider Z, Naria M . Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Gastroprotective NSAIDs on the Gastrointestinal Tract: A Narrative Review. Cureus. 2023; 15(4):e37080. PMC: 10156439. DOI: 10.7759/cureus.37080. View

15.

Debprasad C, Hemanta M, Paromita B, Durbadal O, Kumar K, Shanta D . Inhibition of NO(2), PGE(2), TNF-α, and iNOS EXpression by Shorea robusta L.: An Ethnomedicine Used for Anti-Inflammatory and Analgesic Activity. Evid Based Complement Alternat Med. 2012; 2012:254849. PMC: 3358043. DOI: 10.1155/2012/254849. View

16.

Bai L, Chen H, Zhou P, Yu J . Identification of Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor in Rheumatoid Arthritis Using Network Pharmacology and Molecular Docking. Front Pharmacol. 2021; 12:690118. PMC: 8175775. DOI: 10.3389/fphar.2021.690118. View

17.

Palomer A, Cabre F, Pascual J, Campos J, Trujillo M, Entrena A . Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models. J Med Chem. 2002; 45(7):1402-11. DOI: 10.1021/jm010458r. View

18.

Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J . Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018; 9(6):7204-7218. PMC: 5805548. DOI: 10.18632/oncotarget.23208. View

19.

Ma Y, Li Y, Li X, Wu Y . Anti-inflammatory effects of 4-methylcyclopentadecanone on edema models in mice. Int J Mol Sci. 2013; 14(12):23980-92. PMC: 3876089. DOI: 10.3390/ijms141223980. View

20.

Brune K, Hinz B . Selective cyclooxygenase-2 inhibitors: similarities and differences. Scand J Rheumatol. 2004; 33(1):1-6. DOI: 10.1080/03009740310004766. View